These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15346097)

  • 1. Improving the pharmacological regimen for patients with diabetes mellitus.
    Marso SP
    Rev Cardiovasc Med; 2004; 5(3):139-47. PubMed ID: 15346097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing the diabetic formulary: beyond aspirin and insulin.
    Marso SP
    J Am Coll Cardiol; 2002 Aug; 40(4):652-61. PubMed ID: 12204494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and heart disease an evidence-driven guide to risk factors management in diabetes.
    Lteif AA; Mather KJ; Clark CM
    Cardiol Rev; 2003; 11(5):262-74. PubMed ID: 12943604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
    Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
    Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of patients with diabetes mellitus type 2 and coronary artery disease].
    Wiersma JJ; Trip MD; Piek JJ
    Ned Tijdschr Geneeskd; 2006 Feb; 150(7):361-6. PubMed ID: 16523798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings?
    Giugliano D; Standl E; Vilsbøll T; Betteridge J; Bonadonna R; Campbell IW; Schernthaner GH; Staels B; Trichopoulou A; Farinaro E
    Acta Diabetol; 2009 Sep; 46(3):173-81. PubMed ID: 19543848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-Angiotensin-Aldosterone system inhibition in prevention of diabetes mellitus.
    Bălută M; Vintilă V; Vintilă M
    Rom J Intern Med; 2004; 42(2):277-88. PubMed ID: 15529618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes mellitus: a cardiovascular perspective.
    Varughese GI; Tomson J; Lip GY
    Int J Clin Pract; 2005 Jul; 59(7):798-816. PubMed ID: 15963208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
    Nathanson D; Nyström T
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic syndrome-x at the turn of the millennium (Theoretical aspects with practical consequences)].
    Halmos T; Jermendy G
    Orv Hetil; 2000 Dec; 141(50):2701-9. PubMed ID: 11189676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming obstacles to effective care of type 2 diabetes.
    Kogan AJ
    Am J Manag Care; 2009 Sep; 15(9 Suppl):S255-62. PubMed ID: 19817514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
    Perkins JM; Davis SN
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.
    Rosenberg DE; Jabbour SA; Goldstein BJ
    Diabetes Obes Metab; 2005 Nov; 7(6):642-53. PubMed ID: 16219008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure control, risk factors and cardiovascular prognosis in patients with diabetes: 30 years of progress.
    Mourad JJ; Le Jeune S
    J Hypertens Suppl; 2008 Sep; 26(3):S7-13. PubMed ID: 19363847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to reduce complications of type 2 diabetes.
    Ullom-Minnich P
    J Fam Pract; 2004 May; 53(5):366-75. PubMed ID: 15125821
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of hypertension in patients with chronic kidney disease and diabetes mellitus.
    Palmer BF
    Am J Med; 2008 Aug; 121(8 Suppl):S16-22. PubMed ID: 18638614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin-system blockade in the prevention of diabetes.
    Ostergren J
    Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S13-21. PubMed ID: 17320999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing heart failure in patients with diabetes.
    Srikanthan P; Hsueh W
    Med Clin North Am; 2004 Sep; 88(5):1237-56. PubMed ID: 15331315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the pharmacotherapeutic options for treating type 2 diabetes.
    Kruger DF
    Diabetes Educ; 2008; 34 Suppl 3():60S-65S. PubMed ID: 18525066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.